COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,800 Articles (22,527 medRxiv, 8,273 bioRxiv)

Most recent first Previous |  Page 1755: Articles 17541-17550  | Next

A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples
Sancilio, A., D'Aquila, R., MCNALLY, E., Velez, M., Ison, M., Demonbreun, A. R., McDade, T. W.
10.1101/2021.02.14.21251709 — Posted: 2021-02-16
Comparison of SARS-CoV-2 viral load in saliva samples in symptomatic and asymptomatic cases
Bhatta, A., Henkhaus, R., Fehling, H. L.
10.1101/2021.02.12.21251229 — Posted: 2021-02-16
Treatment of irritant contact dermatitis in healthcare settings during the COVID19 pandemic: The emollient Dermol 500 exhibits virucidal activity against influenza A virus and SARS-CoV-2.
Styles, C. T., Vanden Oever, M., Brown, J., Rai, S., Walsh, S., Ryan, F. M., Barclay, W. S., Edgar, R. S.
10.1101/2021.02.12.21251419 — Posted: 2021-02-16
Confirmation of an Inverse Relationship between Bioaerosol Count and Influenza-like Illnesses, Including COVID-19. On the Contribution of Mold Spores
Shah, R. B., Shah, R. D., Retzinger, D. G., Retzinger, A. C., Retzinger, D. A., Retzinger, G. S.
10.1101/2021.02.07.21251322 — Posted: 2021-02-16
SARS-CoV2- infection as a trigger of humoral response against apolipoprotein A-1
Pagano, S., Yerly, S., Meyer, B., Juillard, C., Suh, N., LeTerrier, C., Daguer, J.-P., Farrera Soler, L., Barluenga, S., Piumatti, G., Hartley, O., Lemaitre, B., Eberhardt, C. S., Siegrist, C.-A., Eckerle, I., Stringhini, S., Guessous, I., Kaiser, L., Pugin, J., Winssinger, N., Vuilleumier, N.
10.1101/2021.02.12.21251298 — Posted: 2021-02-16
Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter?
Nikolai, O., Rohardt, C., Tobian, F., Junge, A., Corman, V. M., Jones, T. C., Gaeddert, M., Lainati, F., Sacks, J., Seybold, J., Mockenhaupt, F. P., Denkinger, C. M., Lindner, A. K.
10.1101/2021.02.09.21251274 — Posted: 2021-02-16
An analysis of school absences in England during the Covid-19 pandemic
Southall, E. R., Holmes, A., Hill, E. M., Atkins, B. D., Leng, T., Thompson, R. N., Dyson, L. J., Keeling, M. J., Tildesley, M.
10.1101/2021.02.10.21251484 — Posted: 2021-02-16
Severe COVID-19 pneumonia and barotrauma: From the frying pan into the fire.
Kalpakam, H., Bansal, S., Suresh, N. ., Kade, S., Thorbole, A., Mehta, R. M.
10.1101/2021.02.12.21251479 — Posted: 2021-02-16
Mortality from injury, overdose and suicide during the 2020 COVID-19 pandemic, March-July, 2020
Faust, J., Du, C., Mayes, K., Li, S.-X., Lin, Z., Barnett, M. L., Krumholz, H. M.
10.1101/2021.02.13.21251682 — Posted: 2021-02-16
The impact of armed conflict on the epidemiological situation of Coronavirus disease (COVID-19) in Libya, Syria, and Yemen.
Daw, M. A.
10.1101/2021.02.12.21251654 — Posted: 2021-02-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).